0001181431-12-038276.txt : 20120628 0001181431-12-038276.hdr.sgml : 20120628 20120628141153 ACCESSION NUMBER: 0001181431-12-038276 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120626 FILED AS OF DATE: 20120628 DATE AS OF CHANGE: 20120628 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRYCE RICHARD PAUL CENTRAL INDEX KEY: 0001553037 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52811 FILM NUMBER: 12932136 MAIL ADDRESS: STREET 1: C/O PUMA BIOTECHNOLOGY, INC. STREET 2: 10880 WILSHIRE BOULEVARD, SUITE 2150 CITY: LOS ANGELES STATE: CA ZIP: 90024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PUMA BIOTECHNOLOGY, INC. CENTRAL INDEX KEY: 0001401667 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770683487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10880 WILSHIRE BLVD. STREET 2: SUITE 2150 CITY: LOS ANGELES STATE: CA ZIP: 90024 BUSINESS PHONE: (424) 248-6500 MAIL ADDRESS: STREET 1: 10880 WILSHIRE BLVD. STREET 2: SUITE 2150 CITY: LOS ANGELES STATE: CA ZIP: 90024 FORMER COMPANY: FORMER CONFORMED NAME: INNOVATIVE ACQUISITIONS CORP DATE OF NAME CHANGE: 20070601 4 1 rrd349676.xml BRYCE F4 X0305 4 2012-06-26 0 0001401667 PUMA BIOTECHNOLOGY, INC. PBYI 0001553037 BRYCE RICHARD PAUL C/O PUMA BIOTECHNOLOGY, INC. 10880 WILSHIRE BOULEVARD, SUITE 2150 LOS ANGELES CA 90024 0 1 0 0 SR VP, CLINICAL RESEARCH & DEV STOCK OPTION (RIGHT TO BUY) 11.30 2012-06-26 4 A 0 105000 0 A 2022-06-26 COMMON STOCK 105000 105000 D The vesting commencement date ("Vesting Commencement Date") of the option is June 20, 2012. The option vests (i) with respect to one-third (1/3) of the shares underlying the option on the first anniversary of the Vesting Commencement Date and (ii) with respect to 1/36th of the shares underlying the option, on each monthly anniversary of the Vesting Commencement Date thereafter, subject to Reporting Person's continued services with the Issuer. /s/ Richard Paul Bryce 2012-06-28